VRNA - Verona Pharma plc Net Margin

Verona Pharma PLC (VRNA) - corporate logo

The net margin dynamics of Verona Pharma plc (VRNA) reflect the company's dependence on FDA approval and patent protection. Logistic complexities stemming from global conflicts create risks, although a focus on Western markets stabilizes the environment. The current profitability trend is visible on this chart, where -36.40 serves as the current parameter value, helping to assess product implementation efficiency.

Verona Pharma Inc. (VRNA) Net Return on Sales: for the period 07/04/2022 - 10/18/2025

Verona Pharma Inc. (VRNA) - metric breakdowns and financial figures

- market value and analyst target forecast:
General company analysis:Verona Pharma - VRNA
Finished products of Verona Pharma Corp

Sales margins determine the share of net profit in every ruble of revenue, measuring cost management efficiency and the ultimate profitability of the business. An analysis of the net margin of commercial activities allows for an assessment of the potential of Verona Pharma plc (VRNA): following the completion of costly clinical trials, the low cost of drug synthesis during mass distribution should ensure a sharp increase in this indicator.

Who Verona Pharma plc competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin Jyong Biotech Ltd|Net Sales Margin Ligand Corp|Net Sales Margin AMRX|Company Sales Margin Perrigo Company plc|Net Sales Margin ALVO (Alvotech Biopharmaceuticals)|LQDA: Net Return on Sales|Galapagos N.V. - Net Sales Margin|ANIP - Net Sales Margin|MNKD: Net Sales Margin|amphastar.com (AMPH) - Net Sales Margin|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma